DRREDDY's weekly performance was lackluster, with a meager 0.07% return, underperforming its peers. The stock's volatility was relatively moderate at 11.64%, but its Sharpe Ratio of 0.03 indicates that the return was not sufficient to compensate for the risk taken. Compared to its peers, DRREDDY lagged behind DIVISLAB and SUNPHARMA, but outperformed HINDUNILVR. Overall, the stock was relatively risky this week, with a Max Drawdown of -0.65%.

[Volatility: 11.64%]